Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2024 | Echopoint Medical | $5.0M Series A | Parkwalk Advisors, David Grimm | ACF Investors, Albion VC, Evening Fund, Gerald Parloiu, Shane Curran |
| Nov 1, 2016 | Achilles Therapeutics | $16.1M Other Equity | Cancer Research Horizons, Syncona, UCL | Francis Crick Institute |
| May 1, 2016 | Orchard Therapeutics | $31.0M Series A | F-Prime Capital | F-Prime Capital Partners, UCL Technology Fund |
| Oct 23, 2015 | Puridify | $3.4M Series A | — | Imperial Innovations, SR One |
| Jul 1, 2015 | Autifony Therapeutics | $12.0M Series A | — | Soffinova Partners, Imperial Innovations, International Biotechnology Trust, SV Health Investors |
| May 29, 2014 | Puridify | $1.4M Seed | Maina Bhaman, Matthew Foy | — |